The Horatio Alger Award bestowed upon ResMed founder Dr. Peter Farrell underscores the company's decades-long leadership in sleep and respiratory care, bringing its financial performance and competitive strategy into sharper focus for investors.
Trane Technologies (NYSE: TT) reported robust Q4 2025 results, driven by exceptional commercial HVAC demand and a record $7.8 billion backlog. While proactive inventory adjustments pressured residential margins, executives project 12-14% adjusted EPS growth for 2026, fueled by strategic acquisitions and sustained commercial strength.
Goldman Sachs has upgraded BioNTech SE (NASDAQ:BNTX) from Neutral to Buy, raising its price target to $142. The firm highlights the company's pivotal role in next-generation cancer treatments, including immuno-oncology and antibody-drug conjugates (ADCs), as a major catalyst for future growth.
Oshkosh Corporation reported full-year revenue of $10.4 billion and adjusted EPS of $10.79 for 2025. While projecting sales growth to approximately $11 billion in 2026, the company cautioned about near-term softness in its industrial access equipment segment and a significant $200 million tariff impact.
Origin Bancorp (OBK) executives detailed strong profitability gains and a strategic hiring push, positioning the bank to capitalize on merger-driven market shifts and surpass $10 billion in assets.
National Fuel Gas (NFG) reported robust first-quarter earnings, driven by a 29% surge in upstream EBITDA. Executives highlighted progress on pipeline expansions, strategic hedging against volatile gas prices, and the planned acquisition of CenterPoint's Ohio utility, while reaffirming full-year guidance.
Axos Financial Inc. (AX) reported robust second-quarter earnings for fiscal 2026, highlighted by a 23.3% surge in earnings per share and significant loan portfolio expansion, even as it manages industry-wide margin pressures and rising operational costs.
Mako Mining Corp.'s updated resource estimate for its Arizona-based Moss Mine, featuring significant unencumbered silver and a streamlined path to production, is reshaping the company's investment thesis and near-term prospects.
Following a year hampered by supply chain issues and inventory adjustments, advanced materials maker Hexcel signals a turning point, forecasting stronger sales and profitability in 2026 as commercial aircraft production is poised for a multi-year upswing.
Celestica's Q4 2025 results shattered guidance, fueled by its Connectivity & Cloud unit. The company announces a massive capital expenditure surge to over $1 billion in 2026, betting big on sustained demand from hyperscalers for AI and networking infrastructure.
Cullen/Frost Bankers Inc. reports strong quarterly earnings, driven by disciplined credit management and strategic expansion, while outlining a cautious yet opportunistic outlook for 2026 in a shifting rate environment.
SkyWest Airlines reported robust full-year earnings for 2025, overcoming a disruptive government shutdown in Q4. The regional carrier highlighted significant debt reduction, key contract extensions with major partners, and a bullish outlook for 2026 driven by new aircraft deliveries and improved operational leverage.
UPS's ambitious free cash flow target for 2026 appears to secure its hefty dividend, but a closer look reveals reliance on asset sales, deep cost cuts, and reduced capital investment—a strategy that may be mortgaging its long-term expansion.
Newly unsealed correspondence contradicts CEO's prior statements, sparking investor concern amid broader challenges for the electric vehicle maker.
IAMGOLD (TSX:IMG) has reignited drilling at its Anik joint venture in Québec and issued updated production guidance, signaling accelerating operational momentum. The moves come as the gold miner's shares, despite recent volatility, have delivered staggering multi-year returns, highlighting a potential valuation gap.
Tyson Foods reported mixed Q1 FY2026 results, with strong momentum in Prepared Foods and Chicken segments offset by significant challenges in Beef due to constrained cattle supplies. The company also unveiled a new segment reporting structure aimed at enhancing transparency for investors.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
Amid a backdrop of cautious market optimism, companies with significant insider ownership are drawing investor attention. We examine three firms where those closest to the business are putting their money, spanning biotech, advanced semiconductors, and regional banking.
As major indices hold steady amid market volatility, a closer look reveals resilient small-cap banks with strong fundamentals trading at a discount. We analyze three community-focused institutions that may offer investors a compelling opportunity.
NAPCO Security Technologies (NSSC) reported strong fiscal second-quarter results, with record revenue and expanding profitability. The company highlighted the sustained momentum of its high-margin recurring service model and announced a dividend increase.
